ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Breckenridge Announces Final Approval of its ANDA for Roflumilast Tablets
americanpharmaceuticalreview
October 12, 2018Breckenridge Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application for Roflumilast Tablets, 500mcg, generic for Daliresp Tablets by AstraZeneca Pharmaceutical. Breckenridge
Pharma Sources Insight January 2025
